Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Neohepatic Albumin-Bilirubin Scores on Renal Outcomes Following Living-donor Liver Transplantation: Propensity Score Analysis

NCT06340607 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT06340607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06340607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Neohepatic Albumin-Bilirubin Scores on Renal Outcomes Following Living-donor Liver Transplantation: Propensity Score Analysis
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
January 5, 2012
Completion date
December 31, 2022
Enrollment
3,422 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, chronic kidney diseases, graft failure